Tang Bin, Li Sijia, Xiong Yuwan, Tian Ming, Yu Jianbin, Xu Lixia, Zhang Li, Li Zhuo, Ma Jianchao, Wen Feng, Feng Zhonglin, Liang Xinling, Shi Wei, Liu Shuangxin
Department of Nephrology, Blood Purifiction Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Kidney Med. 2020 Mar 12;2(3):354-358. doi: 10.1016/j.xkme.2020.03.001. eCollection 2020 May-Jun.
Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences.
2019冠状病毒病（COVID-19）是由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的一种高传染性疾病。先前关于COVID-19肺炎疫情的研究是基于普通人群的信息。关于COVID-19肺炎血液透析患者的数据有限。本报告描述了一名中心血液透析患者的COVID-19临床特征，以及我们在采取措施预防COVID-19肺炎在中心血液透析患者中传播方面的经验。本报告讨论了血液透析患者中COVID-19的诊断、感染控制和治疗，并根据我们的经验，最后给出了透析机构应对COVID-19的建议。
Zotero 插件